Search Browse Earnings

Adicet Bio, Inc.

Nasdaq:ACET

Pharmaceutical Preparations·BOSTON, MA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Adicet Bio, Inc. — SlamSEC

Revenue

—

Adj. EBITDA

-$121.1M

FY 2025

Net Income

-$117.1M

FY 2025

EPS (Diluted)

-$21.33

FY 2025

Stock Price

$7.21

+2.4%

2026-03-13

52W Range

$6.41 – $17.44

P/E Ratio

-0.3x

Market Cap

$69.2M

Cash

$56.5M

FY 2025

Total Debt

—

Net Cash

$56.5M

Enterprise Value

$12.7M

Debt / EBITDA

0.5x

FY 2025

EV / EBITDA

-0.1x

Employees

—